Skip to main content
SpringerLink
Log in

Diagnosis and Management of Hereditary Sarcoma

  • Chapter
  • First Online:
Rare Hereditary Cancers

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 205))

Abstract

Sarcomas are rare and heterogeneous diseases that affect a younger population than most epithelial cancers. Epidemiologic studies suggest a strong genetic component to sarcomas, and many familial cancer syndromes have been described, in which sarcomas are a feature. The best known of these are the Li–Fraumeni and retinoblastoma syndromes, study of which has been pivotal to elucidating the molecular basis for the cell response to DNA damage and the cell division. Although much has been learnt about cancer biology from the study of sarcoma families, in general clinical management of increased sarcoma risk has lagged behind other cancer predisposition syndromes. With the advent of genomic tools for genetic testing, it is likely that a substantial fraction of sarcoma patients will be identified as carriers of known risk alleles. The translation of this knowledge into effective risk management programs and cancer treatments will be essential to changes in routine clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adela Avila S, Penaloza J, Gonzalez F, Abdo I, Rainville I, Root E, Carrero Valenzuela RD, Garber J (2014) Dysphagia, melanosis, gastrointestinal stromal tumors and a germinal mutation of the KIT gene in an Argentine family. Acta Gastroenterol Latinoam 44:9–15

    Google Scholar 

  • Agaimy A, Vassos N, Croner RS (2012) Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol 5:852–862

    PubMed  PubMed Central  Google Scholar 

  • Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE (2015) Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer 121:286–293

    Article  PubMed  Google Scholar 

  • Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43:1262–1265

    Article  CAS  PubMed  Google Scholar 

  • ANZCTR (2015) A pilot surveillance study investigating whole body magnetic resonance imaging and other diagnostic procedures in people at high risk of cancer. ACTRN 12613000987763 (Online). Available: https://anzctr.org.au/

  • Bachet JB, Emile JF (2010) Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors. Appl Clin Genet 3:85–101

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bachet JB, Landi B, Laurent-Puig P, Italiano A, le Cesne A, Levy P, Safar V, Duffaud F, Blay JY, Emile JF (2013) Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. Eur J Cancer 49:2531–2541

    Article  CAS  PubMed  Google Scholar 

  • Balmer A, Zografos L, Munier F (2006) Diagnosis and current management of retinoblastoma. Oncogene 25:5341–5349

    Article  CAS  PubMed  Google Scholar 

  • Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Baty B, Kivlin J et al (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236:1100–1102

    Google Scholar 

  • Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, Larizza L (2001) Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92:657–662

    Article  CAS  PubMed  Google Scholar 

  • Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528–2531

    Article  CAS  PubMed  Google Scholar 

  • Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3:121–125

    Article  CAS  PubMed  Google Scholar 

  • Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac-De Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li-Fraumeni syndrome From TP53 mutation carriers. J Clin Oncol 33:2345–2352

    Google Scholar 

  • Bougeard G, Sesboue R, Baert-Desurmont S, Vasseur S, Martin C, Tinat J, Brugieres L, Chompret A, de Paillerets BB, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg T, French LFSWG (2008) Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 45:535–538

    Article  CAS  PubMed  Google Scholar 

  • Burn J, Chapman P, Delhanty J, Wood C, Lalloo F, Cachon-Gonzalez MB, Tsioupra K, Church W, Rhodes M, Gunn A (1991) The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet 28:289–296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carballo M, Roig I, Aguilar F, Pol MA, Gamundi MJ, Hernan I, Martinez-Gimeno M (2005) Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation. Am J Med Genet A 132A:361–364

    Article  PubMed  Google Scholar 

  • Carney JA, Stratakis CA (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 108:132–139

    Article  PubMed  Google Scholar 

  • Carney JA, Sheps SG, Go VL, Gordon H (1977) The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 296:1517–1518

    Article  CAS  PubMed  Google Scholar 

  • Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O’connell P et al (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193–201

    Google Scholar 

  • Cancer Genetics and Prevention (2015) Li Fraumeni whole body MRI study. http://www.dana-farber.org

  • Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, Bonaiti-Pellie C (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43–47

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chompret A, Brugieres L, Ronsin M, Gardes M, Dessarps-Freichey F, Abel A, Hua D, Ligot L, Dondon MG, Bressac-de Paillerets B, Frebourg T, Lemerle J, Bonaiti-Pellie C, Feunteun J (2000) P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82:1932–1937

    Google Scholar 

  • Chompret A, Kannengiesser C, Barrois M, Terrier P, Dahan P, Tursz T, Lenoir GM, Bressac-de Paillerets B (2004) PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 126:318–321

    Google Scholar 

  • Chrzanowska KH, Gregorek H, Dembowska-Baginska B, Kalina MA, Digweed M (2012) Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 7:13

    Article  PubMed  PubMed Central  Google Scholar 

  • Ciavarella M, Coco M, Baorda F, Stanziale P, Chetta M, Bisceglia L, Palumbo P, Bengala M, Raiteri P, Silengo M, Caldarini C, Facchini R, Lala R, Cavaliere ML, de Brasi D, Pasini B, Zelante L, Guarnieri V, D’Agruma L (2013) 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis. Gene 515:339–348

    Article  CAS  PubMed  Google Scholar 

  • Cancer Institute New South Wales (2015) Risk management for Li Fraumeni syndrome. eviQ Cancer Treatments Online. www.eviq.org.au

  • Clark SK, Phillips RK (1996) Desmoids in familial adenomatous polyposis. Br J Surg 83:1494–1504

    Article  CAS  PubMed  Google Scholar 

  • Cohen MM Jr (2005) Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 8:287–304

    Google Scholar 

  • Collinson M, Leonard SJ, Charlton J, Crolla JA, Silve C, Hall CM, Oglivie C, James MA, Smithson SF (2010) Symmetrical enchondromatosis is associated with duplication of 12p11.23 to 12p11.22 including PTHLH. Am J Med Genet A 152A:3124–3128

    Article  PubMed  Google Scholar 

  • Crucis A, Richer W, Brugieres L, Bergeron C, Marie-Cardine A, Stephan JL, Girard P, Corradini N, Munzer M, Lacour B, Minard-Colin V, Sarnacki S, Ranchere-Vince D, Orbach D, Bourdeaut F (2015) Rhabdomyosarcomas in children with neurofibromatosis type I: a national historical cohort. Pediatr Blood Cancer 62(10):1733–1738

    Article  CAS  PubMed  Google Scholar 

  • Custodio G, Parise GA, Kiesel Filho N, Komechen H, Sabbaga CC, Rosati R, Grisa L, Parise IZ, Pianovski MA, Fiori CM, Ledesma JA, Barbosa JR, Figueiredo FR, Sade ER, Ibanez H, Arram SB, Stinghen ST, Mengarelli LR, Figueiredo MM, Carvalho DC, Avilla SG, Woiski TD, Poncio LC, Lima GF, Pontarolo R, Lalli E, Zhou Y, Zambetti GP, Ribeiro RC, Figueiredo BC (2013) Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol 31:2619–2626

    Google Scholar 

  • de Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288–1292

    Article  PubMed  PubMed Central  Google Scholar 

  • de Raedt T, Cools J, Debiec-Rychter M, Brems H, Mentens N, Sciot R, Himpens J, de Wever I, Schoffski P, Marynen P, Legius E (2006) Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. Gastroenterology 131:1907–1912

    Article  PubMed  Google Scholar 

  • di Giandomenico S, Frapolli R, Bello E, Uboldi S, Licandro SA, Marchini S, Beltrame L, Brich S, Mauro V, Tamborini E, Pilotti S, Casali PG, Grosso F, Sanfilippo R, Gronchi A, Mantovani R, Gatta R, Galmarini CM, Sousa-Faro JM, D’Incalci M (2014) Mode of action of trabectedin in myxoid liposarcomas. Oncogene 33:5201–5210

    Article  PubMed  Google Scholar 

  • Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327–332

    Article  CAS  PubMed  Google Scholar 

  • Evans DG, O’Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19:1187–1191

    Article  PubMed  PubMed Central  Google Scholar 

  • Evans DG, Wu CL, Birch JM (2008) BRCA2: a cause of Li-Fraumeni-like syndrome. J Med Genet 45:62–63

    Article  CAS  PubMed  Google Scholar 

  • Fan Z, Li J, Du J, Zhang H, Shen Y, Wang CY, Wang S (2008) A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J Med Genet 45:303–308

    Article  CAS  PubMed  Google Scholar 

  • Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721–733

    Article  CAS  PubMed  Google Scholar 

  • Fernebro J, Bladstrom A, Rydholm A, Gustafson P, Olsson H, Engellau J, Nilbert M (2006) Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients. Br J Cancer 95:986–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6:340–351

    Article  PubMed  Google Scholar 

  • Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fletcher CD, Hogendoorn P, Merterns F, Bridge J (eds) (2013) World Health Organisation classification of tumours of soft tissue and bone. IARC Press, Lyon

    Google Scholar 

  • Fresneau B, Brugieres L, Caron O, Moutel G (2013) Ethical issues in presymptomatic genetic testing for minors: a dilemma in Li-Fraumeni syndrome. J Genet Couns 22:315–322

    Article  PubMed  Google Scholar 

  • Gatta G, Van Der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R, Group RW (2011) Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer 47:2493–2511

    Google Scholar 

  • Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250–1256

    Article  CAS  PubMed  Google Scholar 

  • Graham J, Debiec-Rychter M, Corless CL, Reid R, Davidson R, White JD (2007) Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. Arch Pathol Lab Med 131:1393–1396

    PubMed  Google Scholar 

  • Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, Kidd A, Mehes K, Nash R, Robin N, Shannon N, Tolmie J, Swansbury J, Irrthum A, Douglas J, Rahman N (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36:1159–1161

    Article  CAS  PubMed  Google Scholar 

  • Hartmann K, Wardelmann E, Ma Y, Merkelbach-Bruse S, Preussner LM, Woolery C, Baldus SE, Heinicke T, Thiele J, Buettner R, Longley BJ (2005) Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 129:1042–1046

    Article  CAS  PubMed  Google Scholar 

  • Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA (2008) Correlation of kinase genotype and clinical outcome in the North American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and Southwest oncology group. J Clin Oncol 26:5360–5367

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hemminki K, Li X (2001) A population-based study of familial soft tissue tumors. J Clin Epidemiol 54:411–416

    Article  CAS  PubMed  Google Scholar 

  • Hersh JH and American Academy of Pediatrics Committee On Genetics (2008) Health supervision for children with neurofibromatosis. Pediatrics 121:633–642

    Google Scholar 

  • Heymann S, Delaloge S, Rahal A, Caron O, Frebourg T, Barreau L, Pachet C, Mathieu MC, Marsiglia H, Bourgier C (2010) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol 5:104

    Article  PubMed  PubMed Central  Google Scholar 

  • Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580

    Google Scholar 

  • Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP (1998) Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 90:606–611

    Google Scholar 

  • Huson SM, Compston DA, Clark P, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704–711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM (2000) Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 157:1581–1585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668–1671

    Google Scholar 

  • Jones KB, Pacifici M, Hilton MJ (2014) Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research. Connect Tissue Res 55:80–88

    Article  CAS  PubMed  Google Scholar 

  • Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y (2004) Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 202:80–85

    Article  CAS  PubMed  Google Scholar 

  • Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, Bier A, Eichhorn B, Blank C, Kraus C, Kohlhase J, Pauli S, Wildhardt G, Kutsche K, Auber B, Christmann A, Bachmann N, Mitter D, Cremer FW, Mayer K, Daumer-Haas C, Nevinny-Stickel-hinzpeter C, Oeffner F, Schluter G, Gencik M, Uberlacker B, Lissewski C, Schanze I, Greene MH, Spix C, Zenker M (2015) Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer 112:1392–1397

    Article  CAS  PubMed  Google Scholar 

  • Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387–3392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK (2006) Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci 51:1043–1046

    Article  PubMed  Google Scholar 

  • Leoz ML, Carballal S, Moreira L, Ocana T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95–107

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lessnick SL, Ladanyi M (2012) Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Annu Rev Pathol 7:145–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li FP, Fraumeni JF Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747–752

    Google Scholar 

  • Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362

    Google Scholar 

  • LIFSCREEN (2015) Evaluation of whole body MRI for early detection of cancers in subjects with P53 mutation (Online). Available: https://clinicaltrials.gov/ct2/show/record/NCT01461086

  • Lopez-Lerma I, Mollet J, Garcia-Patos V (2015) Trichodysplasia spinulosa in gorlin syndrome treated with vismodegib. JAMA Dermatol 151:458–459

    Article  PubMed  Google Scholar 

  • Lung MS, Trainer AH, Campbell I, Lipton L (2015) Familial colorectal cancer. Intern Med J 45:482–491

    Article  CAS  PubMed  Google Scholar 

  • Maeyama H, Hidaka E, Ota H, Minami S, Kajiyama M, Kuraishi A, Mori H, Matsuda Y, Wada S, Sodeyama H, Nakata S, Kawamura N, Hata S, Watanabe M, Iijima Y, Katsuyama T (2001) Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene. Gastroenterology 120:210–215

    Article  CAS  PubMed  Google Scholar 

  • Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238

    Google Scholar 

  • Marshall JB, Diaz-Arias AA, Bochna GS, Vogele KA (1990) Achalasia due to diffuse esophageal leiomyomatosis and inherited as an autosomal dominant disorder. Report of a family study. Gastroenterology 98:1358–1365

    CAS  PubMed  Google Scholar 

  • Masciari S, Van Den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE (2008) F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 299:1315–1319

    Google Scholar 

  • McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MH, Eeles RA, Thomas DM, Mitchell G (2014) Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol 11:260–271

    Article  CAS  PubMed  Google Scholar 

  • Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomaki K, Tomlinson I, Richard S, Linehan WM (2014) Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 13:637–644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miettinen M, Fetsch JF, Sobin LH, Lasota J (2006) Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 30:90–96

    Article  PubMed  Google Scholar 

  • Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P (2013) Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol 37:234–240

    Article  PubMed  PubMed Central  Google Scholar 

  • Miettinen M, Lasota J (2013) Gastrointestinal stromal tumors. Gastroenterol Clin North Am 42:399–415

    Article  PubMed  PubMed Central  Google Scholar 

  • Miettinen M, Lasota J (2014) Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs)—a review. Int J Biochem Cell Biol 53:514–519

    Article  CAS  PubMed  Google Scholar 

  • Mitchell G, Ballinger ML, Wong S, Hewitt C, James P, Young MA, Cipponi A, Pang T, Goode DL, Dobrovic A, Thomas DM, International Sarcoma Kindred Study (2013) High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort. PLoS One 8:e69026

    Google Scholar 

  • Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P (2008) Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 14:4550–4555

    Article  CAS  PubMed  Google Scholar 

  • Musso N, Caronia FP, Castorina S, Lo Monte AI, Barresi V, Condorelli DF (2015) Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas. Cancer Genet 208:62–67

    Google Scholar 

  • Myhre-Jensen O (1981) A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand 52:287–293

    Article  CAS  PubMed  Google Scholar 

  • National Comprehensive Cancer Network (NCCN) (2014) Genetic/familial high risk assessment: breast and ovarian. Li Fraumeni syndrome management. NCCN Clincal Practgice Guidelines in Oncology, USA

    Google Scholar 

  • Neuhann TM, Mansmann V, Merkelbach-Bruse S, Klink B, Hellinger A, Hoffkes HG, Wardelmann E, Schildhaus HU, Tinschert S (2013) A novel germline KIT mutation (p. L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis. Am J Surg Pathol 37:898–905

    Article  PubMed  Google Scholar 

  • National Institute for Health and Care Excellence (NICE) (2013) Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. NICE clinical guideline 164, UK

    Google Scholar 

  • Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y (1998) Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323–324

    Article  CAS  PubMed  Google Scholar 

  • Ognjanovic S, Olivier M, Bergemann TL, Hainaut P (2012) Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 118:1387–1396

    Article  CAS  PubMed  Google Scholar 

  • Pantaleo MA, Astolfi A, Indio V, Moore R, Thiessen N, Heinrich MC, Gnocchi C, Santini D, Catena F, Formica S, Martelli PL, Casadio R, Pession A, Biasco G (2011) SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J Natl Cancer Inst 103:983–987

    Article  CAS  PubMed  Google Scholar 

  • Pasini B, Matyakhina L, Bei T, Muchow M, Boikos S, Ferrando B, Carney JA, Stratakis CA (2007) Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect. J Clin Endocrinol Metab 92:3728–3732

    Article  CAS  PubMed  Google Scholar 

  • Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA (2008) Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16:79–88

    Article  CAS  PubMed  Google Scholar 

  • Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, Cusano R, Marzocchi C, Garre ML, Clementi M, Scarra GB (2009) Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 149A:1539–1543

    Article  CAS  PubMed  Google Scholar 

  • Ralston SH, Albagha OM (2014) Genetics of Paget’s disease of bone. Curr Osteoporos Rep 12:263–271

    Article  PubMed  Google Scholar 

  • Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290–301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Refae MA, Wong N, Patenaude F, Begin LR, Foulkes WD (2007) Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256–261

    Article  CAS  PubMed  Google Scholar 

  • Robson ME, Glogowski E, Sommer G, Antonescu CR, Nafa K, Maki RG, Ellis N, Besmer P, Brennan M, Offit K (2004) Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia. Clin Cancer Res 10:1250–1254

    Article  CAS  PubMed  Google Scholar 

  • Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ, James PA (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30:4330–4336

    Article  PubMed  Google Scholar 

  • Schmidt LS, Linehan WM (2014) Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis 7:253–260

    Article  PubMed  PubMed Central  Google Scholar 

  • Schneider K, Zelley K, Nichols K, Garber J (2013) Li Fraumeni syndrome (Online). Available: http://www.ncbi.nlm.nih.gov/books/NBK1311/

  • Schultz KA, Yang J, Doros L, Williams GM, Harris A, Stewart DR, Messinger Y, Field A, Dehner LP, Hill DA (2014) DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev 19:90–100

    Article  PubMed  PubMed Central  Google Scholar 

  • Scott CL, Swisher EM, Kaufmann SH (2015) Poly (adp-ribose) polymerase inhibitors: recent advances and future development. J Clin Oncol 33:1397–1406

    Article  CAS  PubMed  Google Scholar 

  • Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24:2570–2575

    Article  PubMed  Google Scholar 

  • SIGNIFY (2015) Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome (Online). Available: https://clinicaltrials.gov/ct2/show/record/NCT01443468

  • Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749

    Article  CAS  PubMed  Google Scholar 

  • Stewart DR, Sloan JL, Yao L, Mannes AJ, Moshyedi A, Lee CC, Sciot R, de Smet L, Mautner VF, Legius E (2010) Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1. J Med Genet 47:525–532

    Article  PubMed  PubMed Central  Google Scholar 

  • Stiller CA, Chessells JM, Fitchett M (1994) Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 70:969–972

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sturt NJ, Clark SK (2006) Current ideas in desmoid tumours. Fam Cancer 5:275–85; discussion 287–8

    Google Scholar 

  • Sugimoto M (2014) A cascade leading to premature aging phenotypes including abnormal tumor profiles in Werner syndrome (review). Int J Mol Med 33:247–253

    CAS  PubMed  Google Scholar 

  • Sung L, Anderson JR, Arndt C, Raney RB, Meyer WH, Pappo AS (2004) Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. J Pediatr 144:666–668

    Article  PubMed  Google Scholar 

  • Thomas DM, Ballinger ML (2015) Etiologic, environmental and inherited risk factors in sarcomas. J Surg Oncol 111:490–495

    Article  PubMed  Google Scholar 

  • Thomas DM, James PA, Ballinger ML (2015) Clinical implications of genomics for cancer risk genetics. Lancet Oncol 16:e303–e308

    Article  PubMed  Google Scholar 

  • Thway K, Fisher C (2014) Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol 18:369–380

    Article  PubMed  Google Scholar 

  • Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bonaiti-Pellie C, Stoppa-Lyonnet D, Frebourg T (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27:e108-e109; author reply e110

    Google Scholar 

  • Tomlinson IP Alam NA Rowan AJ Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA, Multiple Leiomyoma C (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410

    Google Scholar 

  • Turan S, Bastepe M (2015) GNAS spectrum of disorders. Curr Osteoporos Rep 13:146–158

    Article  PubMed  Google Scholar 

  • Veith S, Mangerich A (2015) RecQ helicases and PARP1 team up in maintaining genome integrity. Ageing Res Rev 23:12–28

    Article  CAS  PubMed  Google Scholar 

  • Verdegaal SH, Bovee JV, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San Julian M, Biau DJ, Van der Geest IC, Leithner A, Streitburger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PC, Brand R, Taminiau AH (2011) Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist 16:1771–1779

    Google Scholar 

  • Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, Novokmet A, Finlay J, Malkin D (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12:559–567

    Article  CAS  PubMed  Google Scholar 

  • Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187–192

    Google Scholar 

  • Wagner AJ, Malinowska-Kolodziej I, Morgan JA, Qin W, Fletcher CD, Vena N, Ligon AH, Antonescu CR, Ramaiya NH, Demetri GD, Kwiatkowski DJ, Maki RG (2010) Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol 28:835–840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186

    Google Scholar 

  • Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, Roeb W, Agnew KJ, Stray SM, Wickramanayake A, Norquist B, Pennington KP, Garcia RL, King MC, Swisher EM (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A 108:18032–18037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM (1999) von Recklinghausen’s disease and pheochromocytomas. J Urol 162:1582–1586

    Article  CAS  PubMed  Google Scholar 

  • Worch J, Matthay KK, Neuhaus J, Goldsby R, Dubois SG (2010) Ethnic and racial differences in patients with Ewing sarcoma. Cancer 116:983–988

    Article  PubMed  PubMed Central  Google Scholar 

  • Wu CC, Shete S, Amos CI, Strong LC (2006) Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res 66:8287–8292

    Article  CAS  PubMed  Google Scholar 

  • Young MA, Herlihy A, Mitchell G, Thomas DM, Ballinger M, Tucker K, Lewis CR, Neuhaus S, International Sarcoma Kindred S, Halliday J (2013) The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research. Clin Sarcoma Res 3:11

    Google Scholar 

  • Zhang L, Smyrk TC, Young WF Jr, Stratakis CA, Carney JA (2010) Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol 34:53–64

    Google Scholar 

  • Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79:2125–2131

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Kinghorn Cancer Centre & Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

    David M. Thomas & Mandy L. Ballinger

Authors
  1. David M. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mandy L. Ballinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M. Thomas .

Editor information

Editors and Affiliations

  1. London Bridge Hospital, London, United Kingdom

    Gabriella Pichert

  2. University College London, Guy’s & St Thomas’ NHS Foundation Trust, London, United Kingdom

    Chris Jacobs

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Thomas, D.M., Ballinger, M.L. (2016). Diagnosis and Management of Hereditary Sarcoma. In: Pichert, G., Jacobs, C. (eds) Rare Hereditary Cancers. Recent Results in Cancer Research, vol 205. Springer, Cham. https://doi.org/10.1007/978-3-319-29998-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29998-3_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29996-9

  • Online ISBN: 978-3-319-29998-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation